Most cases of enteric sepsis are caused by both aerobic and anaerobic organisms which form the normal flora of the mouth and lower gastrointestinal tract. This flora is extremely variable and subject to change due to disease and antimicrobial treatment. Bacteriological investigation of patients with severe enteric sepsis is important and should be undertaken before antibiotic treatment is commenced. The choice of antibiotics depends on the nature of the infection and its location. Initially they should be given in maximum dosage. If polymicrobial infection is suspected both aerobes and anaerobes should be covered to prevent bacteraemic shock and abscess formation. If abscesses have formed or the patient fails to respond to appropriate antibiotics, surgical exploration and drainage remain the treatment of choice. Antibiotics often fail to eradicate organisms from established abscesses and are responsible for some serious complications.
which may multiply to become predominant when antibiotics are given. A small proportion of people carry klebsiella and other coli forms in their mouth as normal flora.
Unlike the mouth and lower intestinal tract, the normal stomach does not have a resident flora. Gastric acid reduces the number of organisms swallowed in saliva and food to low levels. However, it is important to realise that many factors influence the nature and the numbers of organisms found in the stomach I and at various other sites in the gastrointestinal tract ( Table 2 ). The numbers of organisms found in the upper small bowel are similar to those found in the stomach but reverse peristalsis may result in organisms from the lower small bowel reaching the duodenum.
Aerobic and anaerobic organisms are present in approximately equal numbers in the lower half of the small bowel. In the colon and rectum, anaerobes induding the important Bacteroides fragilis outnumber facultative organisms like E. coli and streptococci by 1000 to 1. Unlike the bacteroides found in the mouth, Bacteroides fragilis is resistant to penicillin. There is undoubtedly great individual variation in the bacterial flora of the lower gastrointestinal tract but the very large numbers of organisms and the multiplicity of species encountered make it difficult to define changes or differences. Faeces have been shown to contain up to 230 strains of bacteria. 2 
THE ORIGIN AND NATURE OF INFECTIONS

Oesophagus
Rupture or tears of the oesophagus may occur spontaneously but often result from surgery, oesophagoscopy for obstructive lesions or sclerotherapy. Trauma and neoplastic disease are other important causes of breaks in oesophageal integrity. Significant leakage of oesophageal contents into surrounding tissues in the thorax results in mediastinitis. If the leak is large or continuous, infection spreads to involve the pleural space with the development of an empyema. Pericardium may be involved if adhesions form between oesophagus and pericardium. Bacteriological specimens collected early in the infection may contain only streptococci but frequently anaerobic bacteria, commonly fusobacteria, and oral bacteroides may be also present. With large leaks almost all normal oral flora can be isolated from specimens.
A changing bacterial flora after surgical drainage, particularly the detection of coliforms and yeasts, indicates a continuing leak. While most of the aerobic and anaerobic organisms found in the oesophagus and stomach are sensItIve to penicillin, Staphylococcus aureus and other organisms which form {3-lactamases may be present. These and other penicillin-resistant organisms should be excluded by bacteriological cultures.
Stomach and upper small intestine
Trauma, perforation or breakdown of anastomoses are the ways in which organisms escape from the upper gastrointestinal tract. The clinical setting is important because of the various factors which influence the number and types of bacteria found in the stomach. Depending on the condition predisposing to leakage, there may be a few or many organisms present. Food, mucus, blood and other proteinaceous material have an adverse effect on recovery as these act as an adjuvant providing protection for bacteria. 3 Patients who are' admitted as an acute emergency following perforation or trauma generally have only small lIumbers of bacteria present in the stomach and peritoneal cavity. These are usually sensitive to penicillin. Coli forms may be present and need to be considered when treatment is initiated.
Biliary tract
Infections which involve the biliary tract or complicate pancreatitis by causing septicaemia or infecting pancreatic pseudo cysts are often due to a single organism. E. coli or klebsiella are the most commonly implicated organisms but Clostridium perfringens, streptococci or less commonly Bacteroides fragilis may be involved. Pseudomonas aeruginosa may occasionally cause biliary tract infection in patients who have had invasive investigations of the common bile duct. Bacteraemia is common in these infections and can be detected by blood culture. Patients with long-standing obstructive lesions of the biliary tract may have polymicrobial infections with multi-resistant coliforms predominating if they have had repeated courses of antibiotics.
Lower small bowel, colon and rectum
Peritonitis or localised infection arises from the lower small intestine or proximal colon as the result of appendicitis, trauma or following operation. Spillage of liquid bowel contents generally results in gross peritoneal soiling and spreading peritonitis. Infection arising from the distal colon often leads directly to abscess formation without diffuse spreading peritonitis. J Infections arising from the lower alimentary tract are polymicrobial in nature with Bacteroides fragilis predominating. Prophylactic antibiotics, however, can have a major effect on the organisms found in these infections.
Intra-abdominal abscesses
In a large study4 intra-abdominal abscesses were found to be located intra peritoneally in 360/0, retroperitoneally in 38% and were visceral in 26%. Diffuse spreading peritonitis from any cause can result in intraperitoneal abscess formation in the subphrenic or subhepatic spaces, in the paracolic gutters, in the pelvis or among folds of omentum and bowel. The location of most abscesses is determined by the site and extent of the leak. Broadly speaking, infections arising from the upper alimentary tract, biliary tract and splenic flexure localise to the subhepatic and subphrenic spaces or the paracolic gutters. 4 • 5 Abscesses arising from the upper tract may contain a wide variety of bacteria in addition to anaerobes. Abscesses arising from biliary tract or gall bladder generally contain coli forms as well as streptococci and anaerobes.
Abscesses anslllg from a perforated appendix, distal colon, rectum and female genital tract tend to form in the lower right abdominal quadrant and pelvis. 4 They are polymicrobial in nature and frequently contain four to eight different species of aerobic and anaerobic bacteria. Bacteroides fragilis, streptococci and coliforms should be assumed to be present until proved otherwise by appropriate bacteriological investigations. Altemeier 4 drew attention to the unusually long period of morbidity associated with intraabdominal abscesses and found that retroperitoneal abscesses had a mortality of 100070 if they were not drained.
During the early spread of infection and before localisation occurs, E. coli and other coliforms frequently cause bacteraemia and shock. In experimental peritoneal infections, these organisms are responsible for the early death of animals. 6 Later, Bacteroides fragilis and other anaerobic Gram-negative bacteria are important in causing abscesses. They are frequently accompanied by anaerobic and micro-aerophilic streptococci. The importance of coliforms early in infection and anaerobes later underlies the rationale for using antibiotics effective against both groups or organisms and will be considered in more detail later.
Liver abscesses
Liver abscesses commonly have their origin in the alimentary tract, but may arise from infections in other intra-abdominal organs. However, they may occur as metastatic abscesses in bacteraemia with pyogenic organisms such as Staphylococcus aureus. The bacteriology of hepatic abscesses, therefore, depends on the nature of the underlying condition. Abscesses may contain a single organism such as Streptococcus milleri or Staphylococcus aureus, but are commonly polymicrobial. Examination of abscess material is the only way in which the aetiology can be determined in cases other than those clearly associated with a septicaemic illness such as staphylococcal bacteraemia or endocarditis.
BACTERIOLOGICAL INVESTIGATIONS
Specimens
Appropriate specimens should be obtained by needle aspiration or at surgery. Microscopic examination of this material provides the most useful guide to antibiotic treatment and the results are immediately available. Aerobic and anaerobic cultures should always be done although the results may not be available for some days. They will detect rapidly growing aerobic and anaerobic organisms within 48 hours. Care must be taken to match the microscopic findings and culture results.
In oesophageal leaks, culture of saliva will determine whether penicillin-resistant organisms such as Staphylococcus aureus or coliforms are present.
In the appropriate setting, blood cultures provide valuable clues to the diagnosis of infection. They should be collected before, and not after, antibiotic treatment is started. In acutely ill patients three or more samples of blood (10 to 15 ml) should be collected over a period of 15-30 minutes and injected into aerobic and anaerobic blood culture broths. In less acutely ill patients a longer interval between sampling is satisfactory. Multiple cultures are necessary as only small numbers of organisms may be intermittently present. Treatment can be commenced immediately after blood cultures have been taken. The isolation of a single organism from blood cultures, in situations where polymicrobial infection is highly suspect, should not be interpreted as indicating that only one organism is involved in the infection. Blood cultures are frequently positive in ascending cholangitis and other biliary infections or in situations where there is portal pyaemia.
CHOICE OF TREATMENT
Many antibiotics are active against either aerobes or anaerobes but none is highly active against all possible pathogens (Table 3) . When the aetiology of the infection has not been determined it is essential to choose an antibiotic or a combination of antibiotics with a broad spectrum of activity. The choice is often a compromise which depends on the nature of the infection, its site, the adequacy of host defenses, previous exposure to antibiotics which may have selected resistant organisms, allergy and the availability and cost of newer antibiotics. Penicillin remains the drug of choice for penicillin-sensitive organisms. The combination of penicillin and metronidazole provides good bactericidal activity against streptococci, clostridia and Gram-negative anaerobes including Bacteroides fragilis. In critically ill patients metronidazole should be given intravenously. When infection is controlled, metronidazole can be given orally used for more than a week. Recent studies suggest that replacement of gentamicin by tobramycin is not cost-effective. 7 Whichever aminoglycoside is used, a loading dose should be given. Maximum maintenance dosage should be used for the first 24 hours. After this, dosage should be determined by the results of peak and trough serum assays. Aminoglycosides are most effective in the early stages of enteric sepsis and are not effective once abscess formation has occurred. The need to continue gentamicin for more than five to seven days should be reviewed and it should be stopped as soon as possible. If an aminoglycoside is still considered essential, netilmicin should be chosen as it appears to be less toxic than gentamicin or tobramycin.
Antibiotics of value in treating patients with enteric sepsis
The combination of penicillin, gentamicin and metronidazole has the advantage that treatment can eventually be modified by stopping the unnecessary component when bacteriological results become available. However this combination does not provide optimal treatment for Staphylococcus aureus. If this organism is present, penicillin should be replaced by flucloxacillin, a cephalosporin or lincomycin. The ultimate choice depends on the presence and importance of other organisms in the infective process. Although clindamycin is more active than lincomycin, its greater antibacterial activity is only a clear advantage when oral treatment is used.
The increased activity of the newer (3-lactam antibiotics against both aerobes and anaerobes and their lack of nephrotoxicity makes them attractive alternatives to aminoglycosides. Cefoxitin and the newer (3-lactams such as latamoxef and cefotaxime have been shown to be as effective as clindamycin and an aminoglycoside in the treatment of intraperitoneal sepsis. 8 ,9 The main weakaesses of these antibiotics lies in their ineffectiveness against Pseudomonas aeruginosa, enterobacters and other cephalosporinaseproducing organisms. Streptococcus faecalis (enterococci) are also resistant. They are also less effective than metronidazole against bacteroides. In cases where these organisms are present another antimicrobial agent such as metronidazole or lincomycin needs to be used. 10 Monotherapy is not recommended for the management of polymicrobial infections in immunocompromised patients. II Ticarcillin or piperacillin combined with gentamicin should be used if Pseudomonas aeruginosa is present. Tobramycin is slightly more active than gentamicin against pseudomonas strains and can be used as an alternative to gentamicin.
The management of two types of infection requires special mention. These are biliary tract infections and abscesses. Aminopenicillins such as amoxycillin do not provide adequate treatment for klebsiellas which are relatively common causes of biliary sepsis. In this situation penicillin and gentamicin or a cephalosporin are the drugs of choice for initial treatment. The most appropriate maintenance treatment should be chosen when blood culture results are known.
Antibiotics are not effective in killing organisms in established abscesses, even though bactericidal levels are commonly found. This may be due to the organisms being metabolic ally inactive and not dividing 6 and therefore not susceptible to antibiotics.
Duration of treatment
With adequate surgery, antibiotic treatment for longer than five to seven days may not be necessary. High risk patients, including those with impaired immune responses, frequently require antibiotics for 10-14 days. In these patients, antibiotics should be continued until signs and symptoms of infection resolve completely. Patients with multiple small abscesses in the liver or elsewhere which are not amenable to surgical drainage should be treated for six weeks or more with appropriate antibiotics or until CAT scans or other investigations show that the abscesses have resolved.
Failure of treatment or relapse of infection
Failure to improve within five to seven days is frequently associated with inadequate surgical drainage of abscesses, continuing abscess formation or leakage of intestinal contents and organisms into the peritoneal cavity. Patients with multiple organ failure have a particularly poor prognosis in this situation. 12 Several studies suggest that earlier surgery and re-exploration improve the prognosis for these patients. 12, 13 If the patient is not improving antibiotic therapy should be reviewed and the treatment changed to ensure that all the important organisms present are adequately treated. After prolonged antibiotic treatment, enterococci, multi-resistant coliforms, Staphylococcus aureus, Pseudomonas aeruginosa and candida may be difficult to control. Gram-negative bacteria may cause secondary pulmonary infection or complicate the intra-abdominal infection. Candida can be a problem in immunocompromised patients but seldom seems to cause significant extra-intestinal infection in other types of patient, though colonisation of intravenous devices may occur. Patients who improve initially and then suffer a relapse may be controlled by changing antibiotics. However, they should be carefully assessed to detect infection requiring surgical correction. If surgery is not indicated and improvement does not occur after two weeks of treatment, antibiotics should be stopped and the subsequent progress of the patient observed. Abscesses which become obvious late in convalescence should be drained.
Complications of treatment
The major complications related to antibiotic treatment of severe intra-abdominal sepsis are shown in Table 5 . Prolonged treatment with broad spectrum antibiotics results in selection of multi-resistant organisms. Those causing most problems are the aerobic Gram-negatives, especially coliforms and Pseudomonas aeruginosa but enterococci frequently survive cephalosporin and aminoglycoside treatment and cause infection. Secondary infection due to multi-resistant Staphylococcus aureus is common in patients who require hospital treatment for long periods.
Intra-abdominal infections with multiresistant organisms are difficult to treat and patients with these organisms should be very carefully assessed before further antibiotics are given. When resistant organisms are found in drainage material from intra-abdominal infections they often indicate continuing Care, Vol. 13, No. 3, August, 1985 leakage from the bowel. Closure of the fistula should be considered rather than antibiotics treatment.
Anaesthesia and Intensive
Patients with multiple organ failure following intra-abdominal sepsis are particularly prone to develop secondary pulmonary infections. These are mainly due to resistant Gram-negatives or multi-resistant Staphylococcus aureus. If pulmonary infection is diagnosed, appropriate antibiotics should be chosen to cover this and the intra-abdominal sepsis. Treatment should be limited, if possible, to less than seven days. Infections due to organisms which form cephalosporinases should not be treated with cefotaxime or other cephalosporins.
Intravenous-associated infections are common in patients requiring prolonged intravenous therapy and parenteral nutrition. The onset of fever in a patient who is otherwise improving, or the isolation of skin organisms or others from blood cultures may indicate colonisation of the intravenous device. If confirmed by repeated culture or examination of the intravenous drip site, the intravenous line should be removed. Antibiotics should only be used to control these infections if the bacteraemia or candidaemia persists after the intravenous device is removed. The choice of antimicrobial agent will depend on the sensitivity of the isolate.
Antibiotic associated colitis may develop in patients with intra-abdominal sepsis on antibiotics. Faecal specimens should be examined for C. difficile toxin and for other organisms such as candida which can cause superinfection. Management of these patients is difficult since continuing parenteral antibiotic treatment may be essential. In addition the patient may have ileus or be on nasogastric suction with the result that appropriate oral treatment with vancomycin, metronidazole or bacitracin cannot be given. In this situation intravenous or rectal metronidazole may be tried. If the condition is severe with pseudomembrane formation, it may be necessary to stop all antibiotics except those active against C. difficile.
Allergy to antimicrobial agents may be responsible for fever, rashes, deteriorating renal function or other symptoms. It may mimic infectious complications and must be considered in all patients who deteriorate. If doubt exists, all antibiotics should be stopped and the patient's course watched closely for several days.
Intra-abdominal sepsis remains a major cause of morbidity and mortality in patients in hospital. While newer methods of investigation, more aggressive surgery and more active antibiotics have improved the prognosis for many patients, there is still considerable room for improvement.
